Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome.
OBJECTIVE
To describe the use of continuous subcutaneous heparin infusion in the treatment of 2 cases of Trousseau's syndrome.


METHODS
Two patients with metastatic carcinoma presented to the hospital with acute coagulopathies consistent with a diagnosis of Trousseau's syndrome. In both cases conventional anticoagulant therapies proved to be impractical and ineffective.


CONCLUSIONS
Considerable literature suggests that oral anticoagulants such as warfarin are ineffective in the treatment of Trousseau's syndrome. Heparin is more effective for this purpose, although continuous intravenous infusion may prove difficult in the ambulatory setting. Intermittent subcutaneous injections of heparin or low-molecular-weight heparin may not provide reliable anticoagulation for the entire dosage interval. Although the use of continuous subcutaneous infusion of heparin has been used for anticoagulation during pregnancy, this is the first report of the use of sodium heparin administered by continuous subcutaneous infusion in the treatment of Trousseau's syndrome.


CONCLUSIONS
Continuous subcutaneous heparin infusion may be an effective option for the treatment of Trousseau's syndrome in the ambulatory setting.
Alderman
C P
CP
Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia.
McClure
A F
AF
Jersmann
H P
HP
Scott
S D
SD
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000150:complications; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009382:Neoplasms, Unknown Primary / Q000150:complications; D010257:Paraneoplastic Syndromes / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology; D012008:Recurrence; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D006493:Heparin